Some epigenetic aging clocks respond to treatment far more than others, a pooled analysis of 51 studies finds

Testing whether anything slows human aging has a built-in problem: the obvious way to find out takes decades. That is why “biological age” measured from a blood sample is so appealing. Try a new drug or diet, retest, and see whether the number has gone down. A new analysis pooling 51 intervention studies, covering 3,128 blood samples, asks a question that should come first: do these measures actually respond to anything?

The answer is yes, but unevenly. A newer group of clocks, built to predict death and the pace of aging, responded most consistently, and others responded less. Drugs moved them more than supplements or lifestyle changes, and whether any of this translates into a longer life remains an open question.

What is an epigenetic clock?

Your DNA sequence stays largely fixed through life, but the chemical tags attached to it do not. One common type, called a methylation mark, changes in fairly predictable ways as people age. An epigenetic clock is a formula that reads a set of those marks, usually from a blood sample, and turns them into an estimate of age.

The first clocks were trained to match a person’s age in years. Later ones were trained to predict things that matter more, such as the risk of dying or how fast someone’s body is aging. Because each was built differently, they do not always behave the same way.

Clocks are already known to predict health outcomes. What has been missing, as the authors put it, is evidence that they respond to interventions. That matters because a clock that cannot detect change is useless for judging whether a treatment works.

How were the epigenetic clocks put to the test?

Writing in Nature Medicine, the researchers built a database called TranslAGE. It brings together 51 studies, some publicly available and some from a private company, TruDiagnostic, in which people’s blood was sampled before and after an intervention. The interventions ranged from diets and exercise to drugs such as metformin, rapamycin and semaglutide, supplements such as omega-3 fatty acids and folate, and medical procedures.

Instead of relying on whichever clock each original study happened to report, the team recalculated the same 16 prominent clocks for every study, along with 94 other methylation-based measures. That consistency is the point. It lets the clocks be compared on equal terms rather than cherry-picked.

As a check, they also ran the clocks on control groups and on events expected to speed aging. Those aging events pushed the clocks up, while interventions pulled them down, which suggests the changes were not random noise.

Which clocks and treatments showed the biggest changes?

Clocks trained to predict mortality or pace of aging showed the strongest responses across all interventions, and they tended to agree with one another. The authors recommend two, DunedinPACE and PCGrimAge, as priorities for future trials.

Among treatments, drugs stood out. Anti-inflammatory anti-TNF therapies and metformin consistently produced strong changes, more than supplements, diets or lifestyle changes did. Results were most reliable for interventions that shifted the same measures across several studies, including anti-TNF drugs and the Mediterranean diet.

The type of person mattered too. Effects were larger in studies of people with existing disease, probably because there was more biological disruption to correct. A clock trained on younger, healthier people, DunedinPACE, was more sensitive in healthier groups.

Is a one-year drop in epigenetic age meaningful?

The pooled effects can look small on paper. The authors point out that for widely used clocks, even a modest-looking effect corresponds to roughly a one-year shift in estimated age, which they argue is not trivial.

Still, here is the part to be clear about. Nobody has yet established how much a clock needs to change to mean a real health benefit. The authors say it is still unclear whether short-term changes correspond to long-term improvements in disease, healthspan or lifespan. Some clocks were also built partly from inflammation markers, so a drop may partly reflect calmer inflammation rather than slower aging itself.

The pooled studies were also very different from one another in age, design and length, which the authors acknowledge limits how far the results can be pushed.

What does this mean for biological age tests?

This study was designed to help researchers pick measures for clinical trials, not to judge tests offered to individuals. It does show that clock choice matters a great deal: a disappointing result on one clock may simply reflect a clock that does not respond well.

For individuals, that cuts against reading too much into a single retest after a lifestyle change. MedlinePlus says a healthy lifestyle for older adults includes healthy eating, regular physical activity and staying at a healthy weight. Those habits are worth pursuing for their own sake, whatever a biological age score says.